Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 9;8(12):798.
doi: 10.3390/nu8120798.

Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Affiliations
Free PMC article
Review

Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Qianying Zhang et al. Nutrients. .
Free PMC article

Abstract

The aim of this systematic review is to assess whether metformin could change the concentration of serum homocysteine (Hcy) with and without simultaneous supplementation of B-group vitamins or folic acid. A literature search was conducted in PubMed, EmBase, and Cochrane Central Register of Controlled Trials (CENTRAL) to identify randomized controlled trials (RCTs) reporting the concentration of serum Hcy in metformin-treated adults. Meta-analysis was applied to assess the association between metformin and the changes of Hcy concentration. Twelve publications were included in this study. In the overall analysis, metformin administration was not statistically associated with the change of Hcy when compared with the control treatment (mean difference (MD), 0.40 μmol/L; 95% confidence interval (CI), -0.07~0.87 μmol/L, p = 0.10). In the subgroup analysis, metformin was significantly associated with an increased concentration of Hcy in the absence of exogenous supplementation of folic acid or B-group vitamins (MD, 2.02 μmol/L; 95% CI, 1.37~2.67 μmol/L, p < 0.00001), but with a decreased concentration of serum Hcy in the presence of these exogenous supplementations (MD, -0.74 μmol/L; 95% CI, -1.19~-0.30 μmol/L, p = 0.001). Therefore, although the overall effect of metformin on the concentration of serum Hcy was neutral, our results suggested that metformin could increase the concentration of Hcy when exogenous B-group vitamins or folic acid supplementation was not given.

Keywords: folic acid; homocysteine; meta-analysis; metformin; systematic review; vitamin B12.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram for study identification and inclusion.
Figure 2
Figure 2
Overall analysis on Hcy concentration and subgroup analysis on Hcy concentration of patients with or without folic acid or B-group vitamins supplementation. The changes from baseline (Mean ± SD) between the two groups were compared. SD, standard deviation; CI, confidence interval; IV, inverse variance.

Similar articles

See all similar articles

Cited by 11 articles

See all "Cited by" articles

References

    1. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., Peters A.L., Tsapas A., Wender R., Matthews D.R. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the american diabetes association and the european association for the study of diabetes. Diabetes Care. 2015;38:140–149. doi: 10.2337/dc14-2441. - DOI - PubMed
    1. Global Guideline for Type 2 Diabetes—2012. [(accessed on 2 January 2016)]. Available online: http://www.idf.org/new-global-guideline-type-2-diabetes-out-now-0.
    1. Liu Q., Li S., Quan H., Li J. Vitamin B12 status in metformin treated patients: Systematic review. PLoS ONE. 2014;9:e100379 doi: 10.1371/journal.pone.0100379. - DOI - PMC - PubMed
    1. Solomon L.R. Disorders of cobalamin (vitamin B12) metabolism: Emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev. 2007;21:113–130. doi: 10.1016/j.blre.2006.05.001. - DOI - PubMed
    1. Selhub J. 5-homocysteine metabolism. Annu. Rev. Nutr. 1999;19:217–246. doi: 10.1146/annurev.nutr.19.1.217. - DOI - PubMed

MeSH terms

Feedback